Current Report Filing (8-k)
17 August 2022 - 10:35PM
Edgar (US Regulatory)
0001840292
false
0001840292
2022-08-15
2022-08-15
0001840292
HLGN:CommonStock0.0001ParValuePerShareMember
2022-08-15
2022-08-15
0001840292
HLGN:WarrantsEachWholeWarrantExercisableForSharesOfCommonStockAtExercisePriceOf11.50PerShareMember
2022-08-15
2022-08-15
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date
of Report (Date of earliest event reported): August 15, 2022
Heliogen,
Inc.
(Exact
name of registrant as specified in its charter)
| Delaware |
|
001-40209 |
|
85-4204953 |
(State
or other jurisdiction of
incorporation) |
|
(Commission
File Number) |
|
(I.R.S.
Employer
Identification
No.) |
130 West Union Street
Pasadena, California 91103
(Address of Principal Executive Offices)
Registrant’s telephone number including area code: (626) 720-4530
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligations of the registrant under
any of the following provisions:
☐
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities
registered pursuant to Section 12(b) of the Act:
| Title
of each class |
|
Trading
Symbol(s) |
|
Name
of each exchange on which registered |
| Common
stock, $0.0001 par value per share |
|
HLGN |
|
New
York Stock Exchange |
| Warrants,
each whole warrant exercisable for shares of Common stock at an exercise price of $11.50 per share |
|
HLGN.W |
|
New
York Stock Exchange |
Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging
growth company ☒
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
| Item
5.02 | Departure
of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers;
Compensatory Arrangements of Certain Officers. |
On
August 15, 2022, David Crane, a member of the Board of Directors (the “Board”) of Heliogen, Inc. (the “Company”),
informed the Company of his decision to resign from the Board, including from the audit committee and the compensation committee of the
Board, effective on September 5, 2022. Mr. Crane’s decision to resign from the Board was not the result of any disagreement relating
to the Company’s operations, policies, or practices.
| Item
9.01 | Financial
Statements and Exhibits. |
(d)
Exhibits.
| Exhibit
Number |
|
Description |
| 104 |
|
Cover
Page Interactive Data File (embedded within the Inline XBRL document). |
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned thereunto duly authorized.
| |
Heliogen,
Inc. |
| |
|
| |
/s/
Christiana Obiaya |
| |
Christiana
Obiaya |
| Dated: August
17, 2022 |
Chief
Financial Officer |
2
Athena Technology Acquis... (NYSE:ATHN)
Historical Stock Chart
Von Mär 2024 bis Apr 2024
Athena Technology Acquis... (NYSE:ATHN)
Historical Stock Chart
Von Apr 2023 bis Apr 2024
